The Current Ratio as of November 2024 (TTM) for PolyPid Ltd. (PYPD) is 1.00

According to PolyPid Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.00. This represents a change of -9.80% compared to the average of 1.11 of the last 4 quarters.

PolyPid Ltd. (PYPD) Historical Current Ratio (quarterly & annually)

How has PYPD Current Ratio performed in the past?

The mean historical Current Ratio of PolyPid Ltd. over the last ten years is 5.69. The current 1.00 Current Ratio has changed 1.65% with respect to the historical average. Over the past ten years (40 quarters), PYPD's Current Ratio was at its highest in in the September 2020 quarter at 27.67. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

PolyPid Ltd. (PYPD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PolyPid Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PolyPid Ltd. (PYPD) Average Current Ratio

How has PYPD Current Ratio performed in the past?

The current Current Ratio of PolyPid Ltd. (PYPD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PolyPid Ltd. (PYPD) Current Ratio vs. Peers

How is PYPD’s Current Ratio compared to its peers?

PolyPid Ltd.’s Current Ratio is less than Cue Biopharma, Inc. (2.22), less than Anixa Biosciences, Inc. (11.31), less than INmune Bio, Inc. (2.59), less than IN8bio, Inc. (1.84), less than eFFECTOR Therapeutics, Inc. (1.03), less than Landos Biopharma, Inc. (4.43), less than Apexigen, Inc. (1.29), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than Angion Biomedica Corp. (1.74), less than Anebulo Pharmaceuticals, Inc. (3.45), greater than Armata Pharmaceuticals, Inc. (0.19), greater than Virpax Pharmaceuticals, Inc. (0.13), less than Vaccitech plc (9.21), less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), less than Revelation Biosciences, Inc. (1.64), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (8.97), less than Pyxis Oncology, Inc. (7.33), less than Zura Bio Limited (10.36), less than Altamira Therapeutics Ltd. (1.38), less than Elevation Oncology, Inc. (17.77),

Build a custom stock screener for PolyPid Ltd. (PYPD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyPid Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PolyPid Ltd. (PYPD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PolyPid Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.